These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 34828946)

  • 21. Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.
    Kones R
    Drug Des Devel Ther; 2011; 5():325-80. PubMed ID: 21792295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adding ezetimibe to statin therapy: latest evidence and clinical implications.
    Vavlukis M; Vavlukis A
    Drugs Context; 2018; 7():212534. PubMed ID: 30023003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipid Lowering Therapy and Circulating PCSK9 Concentration.
    Nozue T
    J Atheroscler Thromb; 2017 Sep; 24(9):895-907. PubMed ID: 28804094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease.
    Nishikido T
    Cardiovasc Diabetol; 2023 Jan; 22(1):20. PubMed ID: 36717882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries.
    Nishikido T; Ray KK
    Front Cardiovasc Med; 2018; 5():199. PubMed ID: 30761308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia.
    Poliakova T; Wellington CL
    Mol Neurodegener; 2023 Nov; 18(1):86. PubMed ID: 37974180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia.
    Ogier N; Amiot MJ; Georgé S; Maillot M; Mallmann C; Maraninchi M; Morange S; Lescuyer JF; Peltier SL; Cardinault N
    Eur J Nutr; 2013 Mar; 52(2):547-57. PubMed ID: 22527287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.
    Lee M; Cheng CY; Wu YL; Lee JD; Hsu CY; Ovbiagele B
    JAMA Neurol; 2022 Apr; 79(4):349-358. PubMed ID: 35188949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary effects on cardiovascular disease risk factors: beyond saturated fatty acids and cholesterol.
    Nicolosi RJ; Wilson TA; Lawton C; Handelman GJ
    J Am Coll Nutr; 2001 Oct; 20(5 Suppl):421S-427S; discussion 440S-442S. PubMed ID: 11603652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials.
    Marston NA; Giugliano RP; Im K; Silverman MG; O'Donoghue ML; Wiviott SD; Ference BA; Sabatine MS
    Circulation; 2019 Oct; 140(16):1308-1317. PubMed ID: 31530008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Dietary Cholesterol in Lipoprotein Metabolism and Related Metabolic Abnormalities: A Mini-review.
    Kapourchali FR; Surendiran G; Goulet A; Moghadasian MH
    Crit Rev Food Sci Nutr; 2016 Oct; 56(14):2408-15. PubMed ID: 26055276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Guideline-Directed Low-Density Lipoprotein Cholesterol Management After Acute Ischemic Stroke: Findings from a National Health Care Service.
    Zafrir B; Aker A; Naoum I; Saliba W
    Am J Cardiol; 2023 Sep; 203():332-338. PubMed ID: 37517128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US.
    Marrett E; Zhao C; Zhang NJ; Zhang Q; Ramey DR; Tomassini JE; Tershakovec AM; Neff DR
    Vasc Health Risk Manag; 2014; 10():237-46. PubMed ID: 24851051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of LDL-C lowering in atherosclerotic cardiovascular disease prevention: Lower for longer is better.
    Mhaimeed O; Burney ZA; Schott SL; Kohli P; Marvel FA; Martin SS
    Am J Prev Cardiol; 2024 Jun; 18():100649. PubMed ID: 38576462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans.
    Aviram M; Dornfeld L; Kaplan M; Coleman R; Gaitini D; Nitecki S; Hofman A; Rosenblat M; Volkova N; Presser D; Attias J; Hayek T; Fuhrman B
    Drugs Exp Clin Res; 2002; 28(2-3):49-62. PubMed ID: 12224378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries.
    Reijman MD; Tromp TR; Hutten BA; Hovingh GK; Blom DJ; Catapano AL; Cuchel M; Dann EJ; Gallo A; Hudgins LC; Raal FJ; Ray KK; Sadiq F; Soran H; Groothoff JW; Wiegman A; Kusters DM; ;
    Lancet Child Adolesc Health; 2024 Jul; 8(7):491-499. PubMed ID: 38759658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.
    Toth PP; Foody JM; Tomassini JE; Sajjan SG; Ramey DR; Neff DR; Tershakovec AM; Hu XH; Tunceli K
    J Clin Lipidol; 2014; 8(1):107-16. PubMed ID: 24528691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients at specialist clinics.
    Morieri ML; Avogaro A; Fadini GP;
    Cardiovasc Diabetol; 2020 Nov; 19(1):190. PubMed ID: 33172454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoprotein(a) and functional outcome of acute ischemic stroke when discordant with low-density lipoprotein cholesterol.
    Dong W; Zhong X; Yuan K; Miao M; Zhai Y; Che B; Xu T; Xu X; Zhong C
    Postgrad Med J; 2023 Oct; 99(1177):1160-1166. PubMed ID: 37624118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of combination therapy is associated with improved LDL-cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
    Ray KK; Aguiar C; Arca M; Connolly DL; Eriksson M; Ferrières J; Laufs U; Mostaza JM; Nanchen D; Bardet A; Lamparter M; Chhabra R; Soronen J; Rietzschel E; Strandberg T; Toplak H; Visseren FLJ; Catapano AL
    Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38861400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.